Cancers
-
Clarithromycin-loaded Nanoparticles Enhance Antibacterial and Anticancer Performance
Researchers have successfully developed clarithromycin-loaded albumin-based nanoparticles (CLA-BSA NPs) that promise to revolutionize the delivery of antibacterial and anticancer drugs. This innovative drug delivery system, detailed in a study published in Pharmaceutics on May 31, 2025, showcases enhanced therapeutic efficacy for clarithromycin, a widely used antibiotic already known for its diverse medical applications. Clarithromycin (CLA) is a broad-spectrum antibiotic commonly…
Read More » -
Study Sheds Light on BRCA Gene Variants in MENA Region
A groundbreaking systematic review has provided unprecedented insights into the genetic factors influencing breast cancer in Middle Eastern and North African (MENA) populations. Published in the Eurasian Journal of Medicine and Oncology, the study analyzed 34 eligible studies involving 5,984 individuals, identifying 385 distinct variants of unknown significance (VUS) in the BRCA1 and BRCA2 genes – the key players in…
Read More »
